Skye Bioscience Inc (SKYE)

Finanzdaten der Skye Bioscience Inc-Aktie (SKYE)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Operating Expenses	12.73%11.06	12.67	14.90	13.26	18.24
Operating Income/Loss	12.73%-11.06	-12.67	-14.90	-13.26	-18.24
Nonoperating Income/Loss	68.55%0.28	0.17	0.45	0.51	0.62
Income/Loss From Continuing Operations Before Tax	13.80%-10.78	-12.51	-14.44	-12.75	-17.62
Income Tax Expense/Benefit	0.00	-	-	-	0.00
	13.77%-10.79	-12.51	-14.44	-12.75	-17.62
Attributable To Parent	13.77%-10.79	-12.51	-14.44	-12.75	-17.62
Available To Common Stockholders, Basic	13.77%-10.79	-12.51	-14.44	-12.75	-17.62
Basic Average Shares	0.03%39.69	39.68	0.01	39.67	39.66
Diluted Average Shares	0.03%39.69	39.68	0.01	39.67	39.66
Basic Earnings Per Share	15.62%-0.27	-0.32	-0.36	-0.32	-0.44
Diluted Earnings Per Share	15.62%-0.27	-0.32	-0.36	-0.32	-0.44